Episode 123: The Secret To Running a Highly Engaged Community with DigitalMarketer’s Community Manager Michelle Dalton

Online communities are all the rage right now, but most brands struggle to create a real community around their products. This week, we’re going to fix that. In this episode, DigitalMarketer’s Community Manager Michelle Dalton is going to show you what goes on behind-the-scenes of DigitalMarketer’s online communities. She explains […]

Online communities are all the rage right now, but most brands struggle to create a real community around their products. This week, we’re going to fix that. In this episode, DigitalMarketer’s Community Manager Michelle Dalton is going to show you what goes on behind-the-scenes of DigitalMarketer’s online communities. She explains what type of content she creates depending on what community she’s creating it for, the tool she’s creating for the DM community right now, and the most important parts of running a highly engaging community challenge.

RESOURCES MENTIONED IN THIS EPISODE

Community Manager Certification Program
DigitalMarketer Engage Facebook Group
DigitalMarketer ELITE Commons Facebook Group
Community Management Specialist | Become a Certified Community Manager
Michelle on LinkedIn
Michelle on Facebook

Thanks so much for joining us this week. Want to subscribe to The DigitalMarketer Podcast? Have some feedback you’d like to share? Connect with us on Apple Podcasts and leave us a review!

Apple Podcasts not your thing? Find us on Spotify, Stitcher, or TuneIn.

The post Episode 123: The Secret To Running a Highly Engaged Community with DigitalMarketer’s Community Manager Michelle Dalton appeared first on DigitalMarketer.

Balmon Hyper

Next Post

Gilead just got the first FDA coronavirus treatment approval, but there are still problems

Fri Oct 23 , 2020
Good afternoon, readers. We’ve written extensively about the emerging therapeutics against the coronavirus. One of the earliest contenders was remdesivir, an antiviral from biotech giant Gilead. It’s not a save-all; but it did just score a coveted distinction as the first Food and Drug Administration (FDA) approved treatment to tackle […]